In the BioHarmony Drug Report Database
Dexlansoprazole
Dexilant, Dexilant Solutab (dexlansoprazole) is a small molecule pharmaceutical. Dexlansoprazole was first approved as Dexilant on 2009-01-30. It is used to treat gastroesophageal reflux, heartburn, and peptic esophagitis in the USA. Dexilant’s patents are valid until 2032-03-05 (FDA).
Trade Name
|
Dexilant, Dexilant Solutab |
|---|---|
Common Name
|
dexlansoprazole |
ChEMBL ID
|
CHEMBL1201863 |
Indication
|
gastroesophageal reflux, heartburn, peptic esophagitis |
Drug Class
|
Antiulcer agents (benzimidazole derivatives) |
Image (chem structure or protein)